Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
183 participants
INTERVENTIONAL
2006-10-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Follow-up Study to Investigate the Effects of a New Infant Formula on Growth and Body Composition
NCT02594683
Evaluation of Cow Milk-Based Formulas - Functional Proteins
NCT00916565
The Effects on Growth of a Non-Routine Infant Formula
NCT00655720
Feeding Study in Premature Infants
NCT00681018
A Study to Evaluate the Effects of a New Formula on the Growth, Safety and Tolerance of Infants With Growth Failure
NCT03563391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Infant formula
Arm 1. extensively hydrolyzed infant formula without probiotics (Nutramigen LIPIL)
Arm 2. partially hydrolyzed infant formula with probiotics
Arm 3. extensively hydrolyzed infant formula with probiotics
2
Infant formula
Arm 1. extensively hydrolyzed infant formula without probiotics (Nutramigen LIPIL)
Arm 2. partially hydrolyzed infant formula with probiotics
Arm 3. extensively hydrolyzed infant formula with probiotics
3
Infant formula
Arm 1. extensively hydrolyzed infant formula without probiotics (Nutramigen LIPIL)
Arm 2. partially hydrolyzed infant formula with probiotics
Arm 3. extensively hydrolyzed infant formula with probiotics
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Infant formula
Arm 1. extensively hydrolyzed infant formula without probiotics (Nutramigen LIPIL)
Arm 2. partially hydrolyzed infant formula with probiotics
Arm 3. extensively hydrolyzed infant formula with probiotics
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
4 Months
4 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mead Johnson Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mead Johnson
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deolinda Scalabrin, MD
Role: STUDY_DIRECTOR
Mead Johnson Nutrition
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3369-6
Identifier Type: -
Identifier Source: secondary_id
3369-6
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.